Massimo Gentile

9PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Other biological sciences not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Rethinking On-Target Off-Tumor Toxicity as a Hematopoietic Continuum.

|Jul 13, 2026
Ferroptosis in Lymphoproliferative Disorders.

|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities.

|Apr 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational Opportunities.

|Apr 02, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Luca Laurenti, Feliciana Guglielmi, Antonio Mosca

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

Pageof 2

Frequent Collaborators

5 joint publications

Santino Caserta

5 joint publications

Fortunato Morabito

5 joint publications

Francesco Mendicino

4 joint publications

Massimo Gentile